CN112349371B

CN112349371B - Chemotherapy patient drug record evaluation method and device

Info

Publication number: CN112349371B
Application number: CN202011291538.4A
Authority: CN
Inventors: 彭美霞; 葛芹; 葛佳楠; 朱琳琳
Original assignee: Nantong First Peoples Hospital
Current assignee: Nantong First Peoples Hospital
Priority date: 2020-11-18
Filing date: 2020-11-18
Publication date: 2021-06-04
Anticipated expiration: 2040-11-18
Also published as: CN112349371A

Abstract

The invention provides a chemotherapy patient drug record evaluation method and a device, which are characterized in that a first preset time is obtained; acquiring first medicine taking record information of a first patient within a first preset time; acquiring first medicine component information and first medicine expense information according to the first medicine taking record information; according to the first medicine component information and the first medicine taking record information, obtaining the taking frequency information and the taking dosage information of each medicine component in the first medicine component information; establishing a target medicine component database; obtaining first illness state information of a first patient, and obtaining first chemotherapy information according to the first illness state information; obtaining preset medicine information according to the first chemotherapy information; acquiring second medicine component information according to preset medicine information; obtaining first average cost information; the first medicine combination of the first patient is determined from the preset medicine information, so that the technical effects of timely evaluating, analyzing and adjusting the chemotherapy medicines of the patient and improving the economic benefit of the hospital are achieved.

Description

Chemotherapy patient drug record evaluation method and device

Technical Field

The invention relates to the technical field of medical treatment, in particular to a method and a device for evaluating a chemotherapy patient drug record.

Background

Chemotherapy is a short term for chemotherapy, and achieves the purpose of treatment by killing cancer cells with chemotherapeutic drugs. Chemotherapy is one of the most effective means for treating cancer at present, and is also called three major treatment means of cancer together with surgery and radiotherapy. Chemotherapy is a systemic treatment, and whatever the route of administration (oral, intravenous, body cavity administration, etc.), the chemotherapeutic drugs are distributed throughout most organs and tissues of the whole body along with the blood circulation. Therefore, chemotherapy is the main treatment for some tumors prone to systemic dissemination and for tumors in the middle and late stages that have metastasized.

However, the applicant of the present invention finds that the prior art has at least the following technical problems:

in the prior art, when a chemotherapy scheme is established for a chemotherapy patient, the drug is required to be evaluated and adjusted according to the condition of the patient. However, when adjusting the chemotherapy drugs, it usually takes a lot of time to perform drug screening and screening on the premise of ensuring the chemotherapy effect and the physical condition of the patient, thereby reducing the work efficiency and affecting the treatment of other patients.

Disclosure of Invention

The embodiment of the invention provides a chemotherapy patient drug record evaluation method and a chemotherapy patient drug record evaluation device, which solve the technical problems that in the prior art, when a doctor adjusts chemotherapy drugs, on the premise of ensuring the chemotherapy effect and the physical condition of a patient, a large amount of time is generally spent on drug investigation and screening, so that the working efficiency of the doctor is reduced, the treatment of other patients is influenced, the chemotherapy drugs of the patient are evaluated, analyzed and adjusted in time, intelligent correction and decision-making are carried out for the subsequent chemotherapy procedures, the hospitalization time and the medical cost of the patient are reduced, and the economic benefit of a hospital is improved.

In view of the above, embodiments of the present application are provided to provide a chemotherapy patient drug record evaluation method and apparatus.

In a first aspect, the present invention provides a chemotherapy patient drug record evaluation device, the device comprising: a first obtaining unit, configured to obtain a first preset time, where the first preset time is from a first chemotherapy starting time to a current time of a first patient; a second obtaining unit, configured to obtain first medication record information of the first patient within the first preset time; a third obtaining unit configured to obtain first medicine component information and first medicine cost information based on the first medicine taking record information; a fourth obtaining unit, configured to obtain, from the first medicine component information and the first medicine taking record information, administration frequency information and administration dosage information of each medicine component in the first medicine component information; a first establishing unit for establishing a target pharmaceutical ingredient database according to the administration frequency information and the administration dosage information of each pharmaceutical ingredient; a fifth obtaining unit, configured to obtain first disease condition information of the first patient, and obtain first chemotherapy information of the first patient according to the first disease condition information; a sixth obtaining unit, configured to obtain preset drug information of the first patient according to the first chemotherapy information; a seventh obtaining unit, configured to obtain second pharmaceutical composition information according to the preset pharmaceutical information; an eighth obtaining unit for obtaining first average cost information of the first patient based on the first medication cost information; a first determination unit for determining a first drug combination of the first patient from preset drug information based on the second drug component information, the first average cost information, and a target drug component database.

In a second aspect, the present invention provides a method for chemotherapeutic patient drug record assessment, the method comprising: obtaining a first preset time, wherein the first preset time is from the first chemotherapy starting time to the current time of the first patient; acquiring first medicine taking record information of the first patient within the first preset time; according to the first medicine taking record information, obtaining first medicine component information and first medicine expense information; according to the first medicine component information and the first medicine taking record information, obtaining the taking frequency information and the taking dosage information of each medicine component in the first medicine component information; establishing a target medicine component database according to the administration frequency information and the administration dosage information of each medicine component; obtaining first illness state information of the first patient, and obtaining first chemotherapy information of the first patient according to the first illness state information; obtaining preset medicine information of the first patient according to the first chemotherapy information; acquiring second medicine component information according to the preset medicine information; obtaining first average cost information for the first patient based on the first medication cost information; and determining a first medicine combination of the first patient from preset medicine information according to the second medicine component information, the first average cost information and the target medicine component database.

In a third aspect, the present invention provides a chemotherapy patient drug record evaluation device comprising a memory, a processor and a computer program stored on the memory and executable on the processor, the processor implementing the steps of the device according to any one of claims 1 to 7 when executing the program.

One or more technical solutions in the embodiments of the present application have at least one or more of the following technical effects:

according to the method and the device for evaluating the chemotherapy patient drug record, provided by the embodiment of the invention, a first preset time is obtained, wherein the first preset time is from the first chemotherapy starting time of a first patient to the current time; acquiring first medicine taking record information of the first patient within the first preset time; according to the first medicine taking record information, obtaining first medicine component information and first medicine expense information; according to the first medicine component information and the first medicine taking record information, obtaining the taking frequency information and the taking dosage information of each medicine component in the first medicine component information; establishing a target medicine component database according to the administration frequency information and the administration dosage information of each medicine component; obtaining first illness state information of the first patient, and obtaining first chemotherapy information of the first patient according to the first illness state information; obtaining preset medicine information of the first patient according to the first chemotherapy information; acquiring second medicine component information according to the preset medicine information; obtaining first average cost information for the first patient based on the first medication cost information; according to the second medicine component information, the first average cost information and the target medicine component database, the first medicine combination of the first patient is determined from the preset medicine information, so that the technical problems that in the prior art, when a doctor adjusts the chemotherapy medicines, on the premise that the chemotherapy effect and the physical condition of the patient are guaranteed, the doctor generally needs to spend a large amount of time to conduct medicine investigation and screening, the work efficiency of the doctor is reduced, the diagnosis of other patients is influenced are solved, the chemotherapy medicines of the patient are evaluated, analyzed and adjusted in time, intelligent correction and decision making are conducted on the chemotherapy programs later, the hospitalization time and the medical cost of the patient are reduced, and the technical effect of the hospital economic benefit is improved.

The foregoing description is only an overview of the technical solutions of the present invention, and the embodiments of the present invention are described below in order to make the technical means of the present invention more clearly understood and to make the above and other objects, features, and advantages of the present invention more clearly understandable.

Drawings

FIG. 1 is a schematic flow chart of a method for evaluating a record of a drug administered to a patient undergoing chemotherapy according to an embodiment of the present invention;

FIG. 2 is a schematic structural diagram of a device for recording and evaluating a drug for a chemotherapy patient according to an embodiment of the present invention;

fig. 3 is a schematic structural diagram of another exemplary electronic device in an embodiment of the present invention.

Description of reference numerals: a first obtaining unit 11, a second obtaining unit 12, a third obtaining unit 13, a fourth obtaining unit 14, a first establishing unit 15, a fifth obtaining unit 16, a sixth obtaining unit 17, a seventh obtaining unit 18, an eighth obtaining unit 19, a first determining unit 20, a bus 300, a receiver 301, a processor 302, a transmitter 303, a memory 304, and a bus interface 306.

Detailed Description

The embodiment of the invention provides a chemotherapy patient drug record evaluation method and device, which are used for solving the technical problems that in the prior art, when a doctor adjusts chemotherapy drugs, on the premise of ensuring the chemotherapy effect and the physical condition of a patient, a large amount of time is generally spent on drug investigation and screening, so that the working efficiency of the doctor is reduced, and the treatment of other patients is influenced, thereby achieving the technical effects of timely evaluating, analyzing and adjusting the chemotherapy drugs of the patient, making intelligent correction and decision for the subsequent chemotherapy program, reducing the hospitalization time and medical cost of the patient, and improving the economic benefit of a hospital. Hereinafter, example embodiments according to the present application will be described in detail with reference to the accompanying drawings. It should be apparent that the described embodiments are merely some embodiments of the present application and not all embodiments of the present application, and it should be understood that the present application is not limited to the example embodiments described herein.

Summary of the application

Chemotherapy is a short term for chemotherapy, and achieves the purpose of treatment by killing cancer cells with chemotherapeutic drugs. Chemotherapy is one of the most effective means for treating cancer at present, and is also called three major treatment means of cancer together with surgery and radiotherapy. Chemotherapy is a systemic treatment, and whatever the route of administration (oral, intravenous, body cavity administration, etc.), the chemotherapeutic drugs are distributed throughout most organs and tissues of the whole body along with the blood circulation. Therefore, chemotherapy is the main treatment for some tumors prone to systemic dissemination and for tumors in the middle and late stages that have metastasized. However, in the prior art, when a doctor sets a chemotherapy scheme for a chemotherapy patient, the doctor needs to evaluate and adjust the medicine according to the condition of the patient. However, when a doctor adjusts the chemotherapy drugs, on the premise of ensuring the chemotherapy effect and the physical condition of a patient, a lot of time is usually spent on drug screening and screening, so that the working efficiency of the doctor is reduced, and the diagnosis of other patients is influenced.

In order to solve the technical problems, the technical scheme provided by the invention has the following general idea:

the embodiment of the application provides a chemotherapy patient drug record evaluation device, the device includes: a first obtaining unit, configured to obtain a first preset time, where the first preset time is from a first chemotherapy starting time to a current time of a first patient; a second obtaining unit, configured to obtain first medication record information of the first patient within the first preset time; a third obtaining unit configured to obtain first medicine component information and first medicine cost information based on the first medicine taking record information; a fourth obtaining unit, configured to obtain, from the first medicine component information and the first medicine taking record information, administration frequency information and administration dosage information of each medicine component in the first medicine component information; a first establishing unit for establishing a target pharmaceutical ingredient database according to the administration frequency information and the administration dosage information of each pharmaceutical ingredient; a fifth obtaining unit, configured to obtain first disease condition information of the first patient, and obtain first chemotherapy information of the first patient according to the first disease condition information; a sixth obtaining unit, configured to obtain preset drug information of the first patient according to the first chemotherapy information; a seventh obtaining unit, configured to obtain second pharmaceutical composition information according to the preset pharmaceutical information; an eighth obtaining unit for obtaining first average cost information of the first patient based on the first medication cost information; a first determination unit for determining a first drug combination of the first patient from preset drug information based on the second drug component information, the first average cost information, and a target drug component database.

After the fundamental principle of the present application is introduced, the technical solutions of the present invention are described in detail with reference to the accompanying drawings and specific embodiments, and it should be understood that the specific features in the embodiments and examples of the present application are detailed descriptions of the technical solutions of the present application, and are not limitations of the technical solutions of the present application, and the technical features in the embodiments and examples of the present application may be combined with each other without conflict.

Example one

FIG. 1 is a flow chart of a method for evaluating a drug record of a chemotherapy patient according to an embodiment of the present invention. As shown in fig. 1, an embodiment of the present invention provides a method for evaluating a drug record of a chemotherapy patient, the method comprising:

step 100: obtaining a first preset time, wherein the first preset time is from the first chemotherapy starting time to the current time of the first patient;

step 200: acquiring first medicine taking record information of the first patient within the first preset time;

specifically, the first patient is a patient who is hospitalized for a disease, and the first preset time is a time from the first time the first patient starts chemotherapy to the current time, that is, a total time taken by the first patient from the start of chemotherapy to the present time. Furthermore, first medicine taking record information of the first patient within a first preset time is acquired, wherein the first medicine taking record information includes, but is not limited to, information such as medicine name, medicine type, medicine taking time, medicine taking dose, medicine feeding personnel, administration route and the like of the first patient.

Step 300: according to the first medicine taking record information, obtaining first medicine component information and first medicine expense information;

specifically, after the first medication record information is obtained, first medicine component information and first medicine cost information can be correspondingly obtained from the first medication record information, wherein the first medicine component information is component information of chemotherapy medicines taken by a first patient, and the medicines for chemotherapy are the chemotherapy medicines including antimicrobial medicines, antiparasitic medicines and antitumor medicines. Chemotherapeutic drugs such as alkylating agents (nitrogen mustards, nitrosoureas, methane sulfonates, etc.), antimetabolites (folic acid, pyrimidine, purine analogs, etc.), antitumor antibiotics (anthracyclines, mitomycins, bleomycin, actinomycins, etc.), antitumor botanicals (vinblastines, taxols, cephalotaxoids, etc.), hormones, others (platinum complexes, enzymes, etc.), etc., and the first drug cost information is information related to the capital expenditure of the chemotherapeutic drugs taken by the first patient.

Step 400: according to the first medicine component information and the first medicine taking record information, obtaining the taking frequency information and the taking dosage information of each medicine component in the first medicine component information;

specifically, according to first medicine component information and first medicine taking record information of a first patient in a first preset time, the taking frequency information and the taking dosage information of each kind of medicine components in the first medicine component information can be obtained, wherein the taking frequency information is frequency information used by each kind of medicine components, and the taking dosage information is total dosage information used by each kind of medicine components.

Step 500: establishing a target medicine component database according to the administration frequency information and the administration dosage information of each medicine component;

further, in order to achieve the effects of improving the working efficiency of the doctor and improving the efficiency of seeing a doctor when the doctor adjusts the chemotherapy drugs in the later stage, step 500 in the embodiment of the present application further includes:

step 510: obtaining a first degree of association between the frequency of administration information and the first patient;

step 520: obtaining a second degree of association between the administration dosage information and the first patient;

step 530: obtaining a first ratio coefficient of the taking frequency information according to the first correlation degree;

step 540: obtaining a second specific gravity coefficient of the administration dosage information according to the second correlation degree;

step 550: sequentially obtaining a first ratio value of each medicine component according to the first ratio coefficient and the administration frequency information;

step 560: sequentially obtaining a second specific gravity value of each medicine component according to the second specific gravity coefficient and the administration dosage information;

step 570: sequentially obtaining component scores of the medicinal components according to the first specific gravity value and the second specific gravity value;

step 580: and establishing a target medicine component database according to the component scores of the medicine components.

Specifically, after obtaining the information of the administration frequency and the administration dosage of each type of the pharmaceutical ingredients, a target pharmaceutical ingredient database can be correspondingly established, that is, each pharmaceutical ingredient is sequenced in a certain manner, and then the target pharmaceutical ingredient database is formed, and the specific method is as follows: firstly, acquiring a first correlation degree between the administration frequency information and a first patient, wherein the first correlation degree is the influence degree of the administration frequency information on the chemotherapy effect of the first patient, for example, the higher the administration frequency of the patient, the better the chemotherapy effect, etc., then acquiring a second correlation degree between the administration dosage information and the first patient, wherein the second correlation degree is the influence degree of the administration dosage information on the chemotherapy effect of the first patient, then respectively acquiring a first weight coefficient of the administration frequency information and a second weight coefficient of the administration dosage information, wherein the first weight coefficient is the weight coefficient occupied by the administration frequency information, the second weight coefficient is the weight coefficient occupied by the administration dosage information, further, sequentially calculating a first weight value of each medicine component according to the administration frequency information and the first weight coefficient thereof, similarly, according to the second specific gravity coefficient and the administration dosage information, the second specific gravity value of each medicine component is sequentially calculated, the component values of various medicine components are obtained according to the first specific gravity value and the second specific gravity value, and finally, according to the obtained component values, the component values are arranged in a descending order from the high to the low of the component values, so that a target medicine component database is established, wherein the target medicine component database also represents the tolerance of a patient to different medicine components. The chemotherapy medicine adjustment system further achieves the effects that a doctor can conveniently control the data information of the chemotherapy medicine of a patient in real time when the chemotherapy medicine is adjusted in the later period, and intelligent correction and decision making are made for the later chemotherapy scheme, so that the working efficiency of the doctor is improved, and the treatment efficiency is improved.

Step 600: obtaining first illness state information of the first patient, and obtaining first chemotherapy information of the first patient according to the first illness state information;

specifically, the first condition information is the change of the disease of the first patient, including but not limited to the cause of the disease, clinical manifestations of the disease, duration of the disease, and other relevant conditions. From the first disease condition information, first chemotherapy information of the first patient can be obtained correspondingly, wherein the first chemotherapy information is related to historical chemotherapy of the first patient, related to next chemotherapy and the like.

Step 700: obtaining preset medicine information of the first patient according to the first chemotherapy information;

step 800: acquiring second medicine component information according to the preset medicine information;

specifically, after the first chemotherapy information is obtained, the preset drug information of the first patient can be determined from the first chemotherapy information, where the preset drug information is drug information that can be used in the next chemotherapy plan of the first patient in combination with the actual condition of the first patient and the effect of the historical chemotherapy, and then, the second drug component information can be obtained from the preset drug information, where the second drug component information is related to the drug components of each type in the preset drug.

Step 900: obtaining first average cost information for the first patient based on the first medication cost information;

step 1000: and determining a first medicine combination of the first patient from preset medicine information according to the second medicine component information, the first average cost information and the target medicine component database.

Specifically, first average cost information of a first patient can be calculated according to first drug cost information spent by the first patient, wherein the first average cost information is average consumption data of chemotherapy of the first patient, and further, an appropriate first drug combination is determined for the first patient according to second drug component information, the first average cost information and a target drug component database by combining preset drug information, so that whether the second drug component information exists in the target drug component database is judged by comparing the second drug component information which is applicable to the first patient next time with the target drug component database, if so, the tolerance of the first patient to the second drug component information is further analyzed, and therefore, the first drug combination is selected for the first patient from the preset drug information by combining the first average cost information according to the tolerance information of the first patient, the first medicine combination is the medicine combination information required by the first patient in the next chemotherapy, so that the purpose of selecting a proper medicine combination for the patient by combining the tolerance and the family economic condition of the patient and reducing the medical burden of the patient while ensuring the treatment effect of the patient is achieved.

Further, in order to obtain accurate information of the chemotherapy drugs and improve the satisfaction of chemotherapy for the patient, step 600 of the embodiment of the present application further includes:

step 610: obtaining physical sign data information of the first patient;

step 620: obtaining identity feature data information of the first patient;

step 630: obtaining first individual label information of the first patient according to the body sign data information and the identity characteristic data information;

step 640: obtaining first chemotherapy target information of the first patient according to the first chemotherapy information;

step 650: inputting the first individual label information and the first chemotherapy target information into a training model, wherein the training model is obtained by training a plurality of groups of training data, and each group of training data in the plurality of groups comprises: the first individual label information, the first chemotherapy target information and the identification information for identifying the preset chemotherapy curative effect of the patient;

step 660: obtaining output information of the training model, wherein the output information comprises preset chemotherapy effect information of the first patient;

step 670: obtaining first side reaction information of the preset medicine;

step 680: judging whether the first patient can bear the first side reaction information or not according to the individual label information;

step 690: if yes, determining the second drug combination of the first patient from the preset drug information according to the preset chemotherapy curative effect information and the first side reaction information.

Specifically, physical sign data information of a first patient is obtained, wherein the physical sign data is various items of examination data, vital sign data and the like of a body of the first patient after chemotherapy, and identity characteristic data information of the first patient is further obtained, the identity characteristic data information is information related to the identity of the first patient, such as the age, sex, shape and the like of the patient, first individual label information of the first patient can be obtained according to the physical sign data information and the identity characteristic data information, wherein the first individual label information is individual portrait information of the first patient, such as a middle-aged man with a slim figure, good chemotherapy effect, various vital signs and the like of the first patient, further, first chemotherapy target information of the first patient can be obtained according to the first chemotherapy information, wherein the first chemotherapy target information is a main treatment target of the patient to be treated by chemotherapy next, and then obtaining preset chemotherapy curative effect information of the first patient through a neural network model, and then obtaining first side reaction information of the preset medicine according to the preset medicine information, wherein the first side reaction information is that the preset medicine can cause the patient to generate some adverse reactions, and the side reactions are that the medicine generates under the treatment dosage, are inherent effects of the medicine and are mostly slight and predictable. Due to the low selectivity, pharmacological effects are involved in multiple organs, and when one effect is used for therapeutic purposes, the other effects become side effects (also commonly referred to as side effects). For chemotherapy patients, side effects may include nausea, vomiting, poor appetite, alopecia, diarrhea, toxicity to other organs of the body, and the like, and further, according to the individual label information of the patients, whether the first side effect is within the tolerable range of the first patient is judged, and if the first side effect is within the tolerable range of the first patient, according to the preset chemotherapy curative effect information and the first side effect information, the second medicine combination of the first patient is determined from the preset medicine information, namely the second medicine combination is a medicine combination with good curative effect and small side effect in the preset medicine information, so that the effects of selecting more appropriate chemotherapy medicines for the patients according to the combination of the actual conditions and the side effects of the patients, reducing the chemotherapy pain degree of the patients and improving the chemotherapy satisfaction degree of the patients are achieved.

Furthermore, the training model is a neural network model in the machine learning model, and the machine learning model can continuously learn through a large amount of data, further continuously correct the model, and finally obtain satisfactory experience to process other data. The machine model is obtained by training a plurality of groups of training data, and the process of training the neural network model by the training data is essentially the process of supervised learning. The training model in the embodiment of the application is obtained by utilizing machine learning training through a plurality of groups of training data, and each group of training data in the plurality of groups comprises: the first individual label information, the first chemotherapy target information and the identification information for identifying the preset chemotherapy curative effect of the patient. Wherein, the preset chemotherapy effect identification information of the patient is used as supervision data.

Further, preset chemotherapy effect identification information of the patient is used as supervision data and is input into each group of training data, supervision learning is carried out on the first individual label information and the first chemotherapy target information, the identification information of the preset chemotherapy effect of the patient is compared with an output result of the training model, when the identification information of the preset chemotherapy effect of the patient is consistent with the output result of the training model, the group of data supervision learning is finished, and the next group of data supervision learning is carried out; when the two groups of data are inconsistent, the training model carries out self-correction until the output result is consistent with the information of the preset chemotherapy curative effect of the first identified patient, the group of supervised learning is finished, and the next group of data supervised learning is carried out; and (4) through supervised learning of a large amount of data, enabling the output result of the machine learning model to reach a convergence state, and finishing the supervised learning. Through the process of supervising and learning the training model, the preset chemotherapy curative effect information of the patient output by the training model is more accurate, the accurate preset chemotherapy curative effect information of the first patient is obtained, and the effect that the patient selects improper chemotherapy drugs and even causes the phenomenon of aggravation of the disease is avoided.

Further, in order to further achieve the effects of selecting appropriate chemotherapy information for the patient, reducing the pain level of the patient, and improving the chemotherapy efficacy of the patient, step 690 of the embodiment of the present application further includes:

step 691: judging whether the first medicine combination is consistent with the second medicine combination;

step 692: if the first cost information of the first medicine combination is inconsistent with the second cost information of the second medicine combination, respectively obtaining the first cost information of the first medicine combination and the second cost information of the second medicine combination;

step 693: obtaining family burden information of the first patient;

step 694: respectively judging whether the first expense information and the second expense information exceed the family burden information;

step 695: if not, respectively obtaining the side reaction information and the curative effect information of the first medicine combination and the side reaction information and the curative effect information of the second medicine combination;

step 696: and determining whether to use the first medicine combination or the second medicine combination as the target medicine of the first patient according to the side reaction information, the curative effect information and the first cost information of the first medicine combination and the side reaction information, the curative effect information and the second cost information of the second medicine combination.

Specifically, after the second medicine combination is obtained, whether the first medicine combination and the second medicine combination are consistent or not can be judged according to the first medicine combination and the second medicine combination, if the first medicine combination and the second medicine combination are not consistent, first expense information of the first medicine combination and second expense information of the second medicine combination are calculated, the first expense information is information required to be spent by the first medicine combination, the second expense information is information required to be spent by the second medicine combination, further family burden information of the first patient is obtained, wherein the family burden information is family economic condition information of the first patient, and can be analyzed through income and expenditure conditions, fixed asset conditions, debt conditions and the like of a family, then whether the first expense information and the second expense information exceed the family burden information or not is judged, if the first expense information and the second expense information do not exceed the family burden information, the first expense information and the second expense information are still within the bearing range of the family of the first patient, then the side reaction information and the curative effect information of the first medicine combination and the side reaction information and the curative effect information of the second medicine combination are obtained, wherein the side reaction information and the curative effect information of the first medicine combination and the side reaction information and the curative effect information of the second medicine combination can be obtained through big data analysis, namely the big data is used for carrying out data analysis and processing on the side reaction information and the curative effect information of the relevant chemotherapy patients. Further, the side reaction information, the curative effect information and the first cost information of the first medicine combination are comprehensively compared and analyzed with the side reaction information, the curative effect information and the second cost information of the second medicine combination, so as to determine the target medicine combination suitable for the first patient, that is, the score value of the first medicine combination and the score value of the second medicine combination can be determined according to different proportion relations of the side reaction information, the curative effect information and the cost information, for example, the side reaction information has a first proportion coefficient, the curative effect information has a second proportion coefficient and the cost information has a third proportion coefficient, and finally the score value is high to be used as the target medicine of the first patient, that is, the first medicine combination or the second medicine combination is determined to be used as the target medicine of the first patient, so as to further achieve the purpose of selecting the appropriate chemotherapy medicine information for the patient, reduce the pain degree of the patient, reduce the economic burden of the patient and improve the effect of the chemotherapy effect of the patient.

Further, in order to determine whether the first medicine combination needs to be adjusted, so as to improve the intelligent degree and improve the effect of the working efficiency of the doctor, step 1000 in the embodiment of the present application further includes:

step 1010: obtaining second condition information of the first patient;

step 1020: obtaining preset complication information according to the first medicine combination;

step 1030: obtaining a first degree of influence between the second condition information and the preset complication information;

step 1040: obtaining a preset influence threshold range;

step 1010: judging whether the first influence degree exceeds the preset influence threshold range or not;

step 1050: if yes, obtaining a first adjusting instruction;

step 1060: and adjusting the first medicine combination according to the first adjustment instruction and a target medicine component database.

Specifically, second condition information of the first patient is obtained, wherein the second condition information is historical condition information of the first patient, namely other conditions of the first patient besides the first condition, such as hypertension, diabetes and the like. Obtaining preset complication information of the first medicine combination according to the first medicine combination, wherein the preset complication information is related complications which may occur after the first patient takes the first medicine combination, such as extravasation, edema, constipation and the like, further obtaining a first influence degree between the second disease condition information and the preset complication information, namely the influence degree of the second disease condition information on the complications which may occur, then obtaining a preset influence threshold range, comparing the first influence degree with the preset influence threshold range, judging whether the first influence degree exceeds the preset influence threshold range, if the first influence threshold range is exceeded, indicating that the second disease condition information may affect the chemotherapy process of the first patient, and the complications are likely to occur, even aggravate and the like, and therefore, a first adjusting instruction needs to be generated at this time, and then, according to the first adjustment instruction and under the guidance of the target medicine component database, adjusting the first medicine combination of the first patient, and further achieving the effect of determining whether the first medicine combination needs to be adjusted by evaluating the first medicine combination, thereby being beneficial to improving the treatment effect of the patient, improving the treatment level of a hospital, providing data information for the standardized system of chemotherapy, further improving the intelligent degree and improving the working efficiency of a doctor.

Further, in order to achieve the effects of obtaining a more accurate target drug and improving the medical quality, step 696 in this embodiment of the present application further includes:

step 6961: obtaining target dosage information of the first patient according to the target medicine;

step 6962: obtaining a first chemotherapy time for the first patient;

step 6963: after the first chemotherapy session has begun, chemotherapy is administered to the first patient in accordance with the target dose information;

step 6964: obtaining a second preset time;

step 6965: after the second preset time, obtaining first examination information of the first patient;

step 6966: obtaining a first chemotherapy result according to the first examination information;

step 6967: determining whether the first chemotherapy outcome satisfies a predetermined chemotherapy outcome;

step 6968: if so, continuing to treat the first patient according to the target medicine;

step 6969: if the predetermined chemotherapy outcome is not met, determining whether the target drug needs to be adjusted.

Specifically, after obtaining the target drug, the target dose information of the first patient can be obtained accordingly, wherein the target dose information is the dose that the drug corresponding to the target drug should be added during chemotherapy. Then, a first chemotherapy time of the first patient is obtained, wherein the first chemotherapy time is the time when the next chemotherapy of the first patient starts, and then the first patient is subjected to chemotherapy according to the target dose and the target medicine after the first chemotherapy time starts. Further, a second preset time is obtained, where the second preset time is a preset period of time after the chemotherapy is finished, and may be one week, one month, and the like, and this embodiment is not limited specifically. After the second preset time, the first patient can be examined according to the medical advice, that is, the first examination information of the first patient is obtained, and then the first chemotherapy result is obtained according to the first examination information, and the first chemotherapy result is how the chemotherapy effect of the patient is after the current chemotherapy is finished, so that the chemotherapy effect of the patient is controlled. Comparing the first chemotherapy result with a preset chemotherapy result, judging whether the first chemotherapy result meets the preset chemotherapy result, if so, indicating that the selection of the target medicine is more ideal for the curative effect of the first patient, and continuing to treat the first patient according to the target medicine; if the predetermined chemotherapy result is not satisfied, it is further determined whether the target drug needs to be adjusted, i.e., the adjustment needs to be analyzed according to the information about the patient's own condition, the family's will, etc., and if the adjustment is needed, the target drug is adjusted. Therefore, whether the medicine used by the patient needs to be adjusted or not is judged in real time according to the chemotherapy effect of the patient, and the phenomenon that the judgment is not in place and the patient is injured due to the fact that a doctor judges the medicine according to personal experience is avoided.

Further, in order to achieve the effect of correcting and deciding the chemotherapy regimen according to the actual condition of the patient, and serving the doctor and the patient, step 6963 of the embodiment of the present application further includes:

step 696631: obtaining first social attribute information of a first patient;

step 69632: obtaining first free time according to the first social attribute information;

step 69633: judging whether the first vacant time and the first chemotherapy time are overlapped;

step 69634: if so, acquiring the overlapping time;

step 69635: judging whether the overlapping time meets a first preset condition or not;

step 69636: if so, performing chemotherapy on the first patient according to the target dose information after the first chemotherapy time is started;

step 69637: if not, obtaining a first solution, and adjusting the first free time according to the first solution.

Specifically, first social attribute information of a first patient is obtained, wherein the first social attribute information is personal portrait information of the first patient in the society, for example, the first patient is a student, a company employee, a manager, a president, a teacher, and the like, according to the first social attribute information of the first patient, a first free time of the first patient can be determined, for example, when the first patient is a working clan, the first free time is a time after work, when the first patient is a full-time, the first free time is a time taken by a child for help, whether the first free time overlaps with a scheduled first chemotherapy time is determined, if the first free time overlaps with the scheduled first chemotherapy time is obtained, the overlapping time is determined, whether the patient completes the chemotherapy plan is determined, that is, whether the overlapping time meets a first preset condition is determined, if the first preset condition is met, the overlapping time is enough to carry out chemotherapy on the patient, the first patient is subjected to chemotherapy according to the target dose information after the first chemotherapy time is started, if the overlapping time is not enough, a first solution is obtained, then the first free time is adjusted according to the first solution, for example, a company staff applies for a leave to a company, a full-time mother applicant helps to look up children, and the like, and the purposes of correcting and deciding the chemotherapy scheme according to the actual condition of the patient and serving doctors and patients are further achieved.

Example two

Based on the same inventive concept as the chemotherapeutic patient drug record evaluation method in the previous embodiment, the present invention further provides a chemotherapeutic patient drug record evaluation method apparatus, as shown in fig. 2, the apparatus comprises:

a first obtaining unit 11, wherein the first obtaining unit 11 is configured to obtain a first preset time, and the first preset time is from a first chemotherapy starting time to a current time of a first patient;

a second obtaining unit 12, where the second obtaining unit 12 is configured to obtain first medication record information of the first patient within the first preset time;

a third obtaining unit 13, the third obtaining unit 13 being configured to obtain first medicine component information and first medicine cost information according to the first medicine taking record information;

a fourth obtaining unit 14, wherein the fourth obtaining unit 14 is configured to obtain, from the first medicine component information and the first medicine taking record information, the administration frequency information and the administration dosage information of each medicine component in the first medicine component information;

a first establishing unit 15, wherein the first establishing unit 15 is used for establishing a target medicine component database according to the administration frequency information and the administration dosage information of each medicine component;

a fifth obtaining unit 16, where the fifth obtaining unit 16 is configured to obtain first medical condition information of the first patient, and obtain first chemotherapy information of the first patient according to the first medical condition information;

a sixth obtaining unit 17, wherein the sixth obtaining unit 17 is configured to obtain preset drug information of the first patient according to the first chemotherapy information;

a seventh obtaining unit 18, wherein the seventh obtaining unit 18 is configured to obtain second medicine component information according to the preset medicine information;

an eighth obtaining unit 19, wherein the eighth obtaining unit 19 is configured to obtain the first average cost information of the first patient according to the first medication cost information;

a first determination unit 20, wherein the first determination unit 20 is configured to determine a first drug combination of the first patient from preset drug information according to the second drug component information, the first average cost information, and the target drug component database.

Further, the first determining unit further includes:

a ninth obtaining unit for obtaining a first degree of association between the administration frequency information and the first patient;

a tenth obtaining unit for obtaining a second degree of association between the taken dose information and the first patient;

an eleventh obtaining unit configured to obtain a first scale factor of the administration frequency information according to the first degree of association;

a twelfth obtaining unit, configured to obtain a second specific gravity coefficient of the administration dosage information according to the second degree of association;

a thirteenth obtaining unit configured to sequentially obtain a first ratio value of each of the medicine components based on the first ratio coefficient and the administration frequency information;

a fourteenth obtaining unit, configured to sequentially obtain a second specific gravity value of each of the pharmaceutical ingredients according to the second specific gravity coefficient and the administration dose information;

a fifteenth obtaining unit, configured to sequentially obtain component scores of the pharmaceutical components according to the first specific gravity value and the second specific gravity value;

a second establishing unit for establishing a target pharmaceutical ingredient database according to the ingredient scores of the pharmaceutical ingredients.

Further, the apparatus further comprises:

a sixteenth obtaining unit, configured to obtain physical sign data information of the first patient;

a seventeenth obtaining unit, configured to obtain identity feature data information of the first patient;

an eighteenth obtaining unit, configured to obtain first individual label information of the first patient according to the physical sign data information and the identity feature data information;

a nineteenth obtaining unit configured to obtain first chemotherapy target information of the first patient according to the first chemotherapy information;

a first training unit, configured to input the first individual label information and the first chemotherapy target information into a training model, where the training model is obtained by training multiple sets of training data, and each set of training data in the multiple sets includes: the first individual label information, the first chemotherapy target information and the identification information for identifying the preset chemotherapy curative effect of the patient;

a twentieth obtaining unit, configured to obtain output information of the training model, where the output information includes preset chemotherapy efficacy information of the first patient;

a twenty-first obtaining unit, configured to obtain first side reaction information of the preset drug;

the first judging unit is used for judging whether the first patient can bear the first side reaction information or not according to the individual label information;

and the second determining unit is used for determining a second medicine combination of the first patient from the preset medicine information according to the preset chemotherapy curative effect information and the first side reaction information if the first medicine combination can be obtained.

Further, the second determining unit further includes:

a second determination unit configured to determine whether the first medicine combination and the second medicine combination are consistent;

a twenty-second obtaining unit configured to obtain first cost information of the first combination of medicines and second cost information of the second combination of medicines, respectively, if the first and second combinations of medicines are not identical;

a twenty-third obtaining unit for obtaining family burden information of the first patient;

a third judging unit, configured to respectively judge whether the first cost information and the second cost information exceed the family burden information;

a twenty-fourth obtaining unit, configured to obtain, if not exceeding, side reaction information and efficacy information of the first drug combination and side reaction information and efficacy information of the second drug combination, respectively;

a third determination unit configured to determine whether to combine the first drug or the second drug as the target drug of the first patient based on the side reaction information, the efficacy information, and the first cost information of the first drug combination, and the side reaction information, the efficacy information, and the second cost information of the second drug combination.

Further, the apparatus further comprises:

a twenty-fifth obtaining unit, configured to obtain second condition information of the first patient;

a twenty-sixth obtaining unit, configured to obtain preset complication information according to the first medicine combination;

a twenty-seventh obtaining unit, configured to obtain a first degree of influence between the second condition information and the preset complication information;

a twenty-eighth obtaining unit, configured to obtain a preset influence threshold range;

a fourth judging unit, configured to judge whether the first influence degree exceeds the preset influence threshold range;

a twenty-ninth obtaining unit to obtain a first adjustment instruction if exceeded;

a first adjusting unit, configured to adjust the first drug combination according to the first adjustment instruction and a target drug component database.

Further, the apparatus further comprises:

a thirtieth obtaining unit, configured to obtain target dose information of the first patient according to the target drug;

a thirty-first obtaining unit for obtaining a first chemotherapy time of the first patient;

a first execution unit for performing chemotherapy on the first patient according to the target dose information after the first chemotherapy time starts;

a thirty-second obtaining unit, configured to obtain a second preset time;

a thirty-third obtaining unit, configured to obtain the first examination information of the first patient after the second preset time elapses;

a thirty-fourth obtaining unit, configured to obtain a first chemotherapy result according to the first examination information;

a fifth judging unit for judging whether the first chemotherapy result meets a predetermined chemotherapy result;

the second execution unit is used for continuing to treat the first patient according to the target medicine if the first execution unit is met;

a third execution unit to determine if the target drug needs to be adjusted if the predetermined chemotherapy outcome is not met.

Further, the first execution unit further includes:

a thirty-fifth obtaining unit for obtaining first social attribute information of the first patient;

a thirty-sixth obtaining unit, configured to obtain a first free time according to the first social attribute information;

a sixth judging unit configured to judge whether there is an overlap between the first vacant time and the first chemotherapy time;

a thirty-seventh obtaining unit, configured to obtain, if present, an overlap time;

a seventh judging unit, configured to judge whether the overlapping time satisfies a first preset condition;

a fourth executing unit, configured to perform chemotherapy on the first patient according to the target dose information after the first chemotherapy time starts if the target dose information is met;

a fifth execution unit, configured to, if not, obtain a first solution and adjust the first free time according to the first solution.

Various modifications and embodiments of a method for evaluating a record of a chemotherapeutic patient's drug in the first embodiment of fig. 1 are also applicable to a device for evaluating a record of a chemotherapeutic patient's drug in the present embodiment, and the method for implementing the method for evaluating a record of a chemotherapeutic patient's drug in the present embodiment will be apparent to those skilled in the art from the foregoing detailed description of the method for evaluating a record of a chemotherapeutic patient's drug, and therefore, for the sake of brevity of the description, the detailed description thereof will not be provided herein.

EXAMPLE III

Based on the same inventive concept as one of the chemotherapy patient drug record assessment methods in the previous embodiments, the present invention further provides an exemplary electronic device, as shown in fig. 3, comprising a memory 304, a processor 302 and a computer program stored on the memory 304 and executable on the processor 302, wherein the processor 302 executes the program to implement the steps of any one of the chemotherapy patient drug record assessment methods described above.

Where in fig. 3 a bus architecture (represented by bus 300), bus 300 may include any number of interconnected buses and bridges, bus 300 linking together various circuits including one or more processors, represented by processor 302, and memory, represented by memory 304. The bus 300 may also link together various other circuits such as peripherals, voltage regulators, power management circuits, and the like, which are well known in the art, and therefore, will not be described any further herein. A bus interface 306 provides an interface between the bus 300 and the receiver 301 and transmitter 303. The receiver 301 and the transmitter 303 may be the same element, i.e., a transceiver, providing a means for communicating with various other apparatus over a transmission medium. The processor 302 is responsible for managing the bus 300 and general processing, and the memory 304 may be used for storing data used by the processor 302 in performing operations.

according to the method and the device for evaluating the chemotherapy patient drug record, provided by the embodiment of the invention, a first preset time is obtained, wherein the first preset time is from the first chemotherapy starting time of a first patient to the current time; acquiring first medicine taking record information of the first patient within the first preset time; according to the first medicine taking record information, obtaining first medicine component information and first medicine expense information; according to the first medicine component information and the first medicine taking record information, obtaining the taking frequency information and the taking dosage information of each medicine component in the first medicine component information; establishing a target medicine component database according to the administration frequency information and the administration dosage information of each medicine component; obtaining first illness state information of the first patient, and obtaining first chemotherapy information of the first patient according to the first illness state information; obtaining preset medicine information of the first patient according to the first chemotherapy information; acquiring second medicine component information according to the preset medicine information; obtaining first average cost information for the first patient based on the first medication cost information; according to the second medicine component information, the first average cost information and the target medicine component database, the first medicine combination of the first patient is determined from the preset medicine information, so that the technical problems that in the prior art, when a doctor adjusts the chemotherapy medicines, on the premise that the chemotherapy effect and the physical condition of the patient are guaranteed, the doctor generally needs to spend a large amount of time to conduct medicine investigation and screening, the work efficiency of the doctor is reduced, the diagnosis of other patients is influenced are solved, the chemotherapy medicines of the patient are evaluated, analyzed and adjusted in time, intelligent correction and decision making are conducted for the subsequent chemotherapy programs, the hospitalization time and the medical cost of the patient are reduced, and the technical effect of the hospital economic benefit is improved.

As will be appreciated by one skilled in the art, embodiments of the present invention may be provided as a method, system, or computer program product. Accordingly, the present invention may take the form of an entirely hardware embodiment, an entirely software embodiment or an embodiment combining software and hardware aspects. Furthermore, the present invention may take the form of a computer program product embodied on one or more computer-usable storage media (including, but not limited to, disk storage, CD-ROM, optical storage, and the like) having computer-usable program code embodied therein.

The present invention is described with reference to flowchart illustrations and/or block diagrams of methods, apparatus (systems) and computer program products according to embodiments of the invention. It will be understood that each flow and/or block of the flow diagrams and/or block diagrams, and combinations of flows and/or blocks in the flow diagrams and/or block diagrams, can be implemented by computer program instructions. These computer program instructions may be provided to a processor of a general purpose computer, special purpose computer, embedded processor, or other programmable data processing apparatus to produce a machine, such that the instructions, which execute via the processor of the computer or other programmable data processing apparatus, create means for implementing the functions specified in the flowchart flow or flows and/or block diagram block or blocks.

These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including instruction means which implement the function specified in the flowchart flow or flows and/or block diagram block or blocks.

These computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer implemented process such that the instructions which execute on the computer or other programmable apparatus provide steps for implementing the functions specified in the flowchart flow or flows and/or block diagram block or blocks.

It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include such modifications and variations.

Claims

1. A chemotherapy patient drug record evaluation device, wherein the device comprises:

a first obtaining unit, configured to obtain a first preset time, where the first preset time is from a first chemotherapy starting time to a current time of a first patient;

a second obtaining unit, configured to obtain first medication record information of the first patient within the first preset time;

a third obtaining unit configured to obtain first medicine component information and first medicine cost information based on the first medicine taking record information;

a fourth obtaining unit, configured to obtain, from the first medicine component information and the first medicine taking record information, administration frequency information and administration dosage information of each medicine component in the first medicine component information;

a first establishing unit for establishing a target pharmaceutical ingredient database according to the administration frequency information and the administration dosage information of each pharmaceutical ingredient;

a fifth obtaining unit, configured to obtain first disease condition information of the first patient, and obtain first chemotherapy information of the first patient according to the first disease condition information;

a sixth obtaining unit, configured to obtain preset drug information of the first patient according to the first chemotherapy information;

a seventh obtaining unit, configured to obtain second pharmaceutical composition information according to the preset pharmaceutical information;

an eighth obtaining unit for obtaining first average cost information of the first patient based on the first medication cost information;

a first determination unit for determining a first drug combination of the first patient from preset drug information based on the second drug component information, the first average cost information, and a target drug component database.

2. The apparatus of claim 1, wherein the first determining unit further comprises:

3. The apparatus of claim 1, wherein the apparatus further comprises:

4. The apparatus of claim 3, wherein the second determining unit further comprises:

5. The apparatus of claim 1, wherein the apparatus further comprises:

6. The apparatus of claim 4, wherein the apparatus further comprises:

a thirty-second obtaining unit, configured to obtain a second preset time;

7. The apparatus of claim 6, wherein the first execution unit further comprises:

8. A method for chemotherapeutic patient drug record evaluation, the method comprising:

obtaining a first preset time, wherein the first preset time is from the first chemotherapy starting time to the current time of the first patient;

acquiring first medicine taking record information of the first patient within the first preset time;

according to the first medicine taking record information, obtaining first medicine component information and first medicine expense information;

according to the first medicine component information and the first medicine taking record information, obtaining the taking frequency information and the taking dosage information of each medicine component in the first medicine component information;

establishing a target medicine component database according to the administration frequency information and the administration dosage information of each medicine component;

obtaining first illness state information of the first patient, and obtaining first chemotherapy information of the first patient according to the first illness state information;

obtaining preset medicine information of the first patient according to the first chemotherapy information;

acquiring second medicine component information according to the preset medicine information;

obtaining first average cost information for the first patient based on the first medication cost information;

and determining a first medicine combination of the first patient from preset medicine information according to the second medicine component information, the first average cost information and the target medicine component database.